⚠ RecallRadar📷 ScanGuidesOfficial U.S. recall notices, restated plainly

Wells Pharma of Houston LLC: fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC 73702-204-25.

DrugsSource: FDA (drug) · Date: 2026-05-06

Read the official notice at FDA (drug) →

Share on XFacebookRedditEmail

Get alerts for Wells Pharma of Houston

Guides: Which agency handles which recall (FDA vs USDA vs CPSC vs NHTSA)

The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.

Company / brand
Wells Pharma of Houston LLC
Product
fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC 73702-204-25.
Reason / hazard
cGMP deviations.
Classification
Class II
Status
Ongoing
Distribution / sold at
U.S. Nationwide.
Recall initiated
2026-04-01
Code info
Lot 011226204250063, Exp Date 05/14/2026
Product quantity
50 syringes
Voluntary mandated
Voluntary: Firm initiated
City
Houston
State
TX
Country
United States
Event id
98694
Free daily digest + "My products" watchlist

Get the daily digest, and tell us what to watch. Everything is optional except your email.

Free allergen alerts:

Categories:

Privacy: we store only what you enter here, use it only to send recall alerts you asked for, never sell or share it, and you can unsubscribe anytime. Double opt-in: we will email you a confirmation link before sending anything; alerts start only after you confirm. Every email has unsubscribe and manage-watchlist links.